REFR — Research Frontiers Income Statement
0.000.00%
Last trade - 00:00- $63.60m
- $62.46m
- $1.34m
Annual income statement for Research Frontiers, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.828 | 1.26 | 0.54 | 0.91 | 1.34 |
| Cost of Revenue | |||||
| Gross Profit | -1.95 | -1.26 | -2.02 | -1.45 | -0.872 |
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.2 | 3.1 | 3.16 | 2.94 | 2.78 |
| Operating Profit | -2.38 | -1.84 | -2.63 | -2.03 | -1.44 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.34 | -1.85 | -2.67 | -1.91 | -1.31 |
| Net Income After Taxes | -2.34 | -1.85 | -2.67 | -1.91 | -1.31 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2.34 | -1.85 | -2.67 | -1.91 | -1.31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.34 | -1.85 | -2.67 | -1.91 | -1.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.081 | -0.058 | -0.083 | -0.057 | -0.039 |